Physician profile
Benjamin P Wisner
NPI 1396891982
$1,599.98
in general payments reported to CMS, 2019-2025
12 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.00 · 2023: $98.85 · 2024: $765 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Education: $111 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.11 |
| Education | $111.13 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $768.54 | 2024-2025 | |
| Boston Scientific Corporation | $181.80 | 2022-2025 | Upsylon, Advantage System, Axonics |
| Caldera Medical, INC | $140.13 | 2025 | |
| Axonics, INC. | $126.81 | 2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $104.88 | 2025 | Xtandi |
| Swan Valley Medical Incorporated | $82.49 | 2023 | |
| Allergan, INC. | $49.83 | 2022 | |
| Abbvie INC. | $48.26 | 2025 | |
| Immunitybio, INC. | $33.17 | 2025 | |
| Procept Biorobotics Corporation | $28.68 | 2025 | |
| Angiodynamics, INC. | $20.05 | 2025 | Nanoknife |
| Ferring Pharmaceuticals INC. | $15.34 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Wisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.